|
Jay Flatley is President and Chief Executive Officer for Illumina. He has been a Board of Director for the Company since October 1999. Prior to his appointment in 1999 Mr. Flatley was the President and Chief Executive Officer of Molecular Dynamics later acquired by Amersham Pharmacia Biotech in 1998 and now a part of GE Healthcare. Mr. Flatley who was a founder and member of the board of directors for Molecular Dynamics led the company to its initial public offering (IPO) in 1993 in addition to helping the company develop and launch over 15 major instrumentation systems including the world's first capillary-based DNA sequencer.
Prior to joining Molecular Dynamics Mr. Flatley was Vice President of Engineering and Strategic Planning for Plexus Computers a manufacturer of high-performance Unix super-microcomputers. Before his career at Plexus Mr. Flatley was Executive Vice President for Manning Technologies and held various manufacturing positions while working for the Autolab division of Spectra Physics.
Jay received a bachelor of art degree in economics from Claremont McKenna College (Claremont CA) and a bachelor of science and master of science (summa cum laude) in industrial engineering from Stanford University (Stanford CA). Currently he serves as a member for both the board of directors for Illumina and GenVault Corporation. | 